Long-acting bronchodilator use in chronic obstructive pulmonary disease in primary care in New Zealand: a retrospective study of treatment patterns and evolution …

D Milea, SH Yeo, Y Nam… - … Journal of Chronic …, 2021 - Taylor & Francis
Purpose Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, NR AA… - … Journal of Chronic …, 2021 - europepmc.org
Purpose Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - International Journal of …, 2021 - go.gale.com
Purpose: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

[PDF][PDF] Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … Journal of Chronic …, 2021 - pdfs.semanticscholar.org
Purpose: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … journal of chronic …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

[HTML][HTML] Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … Journal of Chronic …, 2021 - ncbi.nlm.nih.gov
Purpose Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … Journal of Chronic …, 2021 - dovepress.com
Purpose: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

[PDF][PDF] Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … Journal of Chronic …, 2021 - scienceopen.com
Purpose: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and …

D Milea, SH Yeo, Y Nam, AAN Rojas… - … Journal of Chronic …, 2021 - dovepress.com
Purpose: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment
for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns …